AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 86 filers reported holding AKCEA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,597,000 | +27.6% | 253,393 | -3.7% | 0.00% | 0.0% |
| Q2 2020 | $3,603,000 | +28.4% | 263,054 | +34.0% | 0.00% | 0.0% |
| Q1 2020 | $2,805,000 | -14.5% | 196,242 | +1.3% | 0.00% | 0.0% |
| Q4 2019 | $3,280,000 | +8.9% | 193,686 | -1.0% | 0.00% | 0.0% |
| Q3 2019 | $3,011,000 | -35.2% | 195,687 | -1.3% | 0.00% | 0.0% |
| Q2 2019 | $4,646,000 | -16.7% | 198,175 | +0.7% | 0.00% | 0.0% |
| Q1 2019 | $5,575,000 | -2.7% | 196,785 | +3.6% | 0.00% | -50.0% |
| Q4 2018 | $5,727,000 | -14.9% | 190,019 | -1.1% | 0.00% | 0.0% |
| Q3 2018 | $6,729,000 | +54.2% | 192,156 | +4.4% | 0.00% | +100.0% |
| Q2 2018 | $4,364,000 | -0.3% | 184,071 | +7.7% | 0.00% | 0.0% |
| Q1 2018 | $4,378,000 | +49.9% | 170,924 | +1.6% | 0.00% | 0.0% |
| Q4 2017 | $2,920,000 | -35.3% | 168,237 | +3.1% | 0.00% | 0.0% |
| Q3 2017 | $4,515,000 | – | 163,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |